Top Eminent Healthcare Group Limited
Top Eminent Healthcare Group Limited Fundamental Analysis
Top Eminent Healthcare Group Limited (6877.HK) shows weak financial fundamentals with a PE ratio of 867.12, profit margin of 0.50%, and ROE of 0.13%. The company generates $0.1B in annual revenue with weak year-over-year growth of -56.69%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -36.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 6877.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak6877.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate6877.HK shows balanced valuation metrics.
Growth Score
Weak6877.HK faces weak or negative growth trends.
Financial Health Score
Moderate6877.HK shows balanced financial health with some risks.
Profitability Score
Weak6877.HK struggles to sustain strong margins.
Key Financial Metrics
Is 6877.HK Expensive or Cheap?
P/E Ratio
6877.HK trades at 867.12 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 6877.HK's PEG of -14.74 indicates potential undervaluation.
Price to Book
The market values Top Eminent Healthcare Group Limited at 1.13 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.00 times EBITDA. This is generally considered low.
How Well Does 6877.HK Make Money?
Net Profit Margin
For every $100 in sales, Top Eminent Healthcare Group Limited keeps $0.50 as profit after all expenses.
Operating Margin
Core operations generate 80.21 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.13 in profit for every $100 of shareholder equity.
ROA
Top Eminent Healthcare Group Limited generates $0.12 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Top Eminent Healthcare Group Limited generates limited operating cash flow of $-8.50M, signaling weaker underlying cash strength.
Free Cash Flow
Top Eminent Healthcare Group Limited generates weak or negative free cash flow of $-8.50M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.00 in free cash annually.
FCF Yield
6877.HK converts -3.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
867.12
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-14.74
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.13
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.001
vs 25 benchmark
ROA
Return on assets percentage
0.001
vs 25 benchmark
ROCE
Return on capital employed
0.20
vs 25 benchmark
How 6877.HK Stacks Against Its Sector Peers
| Metric | 6877.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 867.12 | 18.56 | Worse (Expensive) |
| ROE | 0.13% | 828.00% | Weak |
| Net Margin | 0.50% | -175.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 1.00 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 663.54 | Weak Liquidity |
| ROA | 0.12% | -21308.00% (disorted) | Weak |
6877.HK outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Top Eminent Healthcare Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
535.65%
Industry Style: Value, Dividend, Cyclical
High GrowthEPS CAGR
106.30%
Industry Style: Value, Dividend, Cyclical
High GrowthFCF CAGR
82.49%
Industry Style: Value, Dividend, Cyclical
High Growth